• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于检测多种类型表皮生长因子受体(EGFR)第19外显子缺失的引物和探针组。

A primer and probe set for detecting multiple types of EGFR exon 19 deletions.

作者信息

Chen Tai-Long, Chang John Wen-Cheng, Wang Chih-Liang, Yang Cheng-Ta, Wang Mei-Chia, Chiou Chiuan-Chian

机构信息

Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.

Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Anal Biochem. 2016 Nov 15;513:61-67. doi: 10.1016/j.ab.2016.09.002. Epub 2016 Sep 4.

DOI:10.1016/j.ab.2016.09.002
PMID:27601284
Abstract

EGFR exon 19 deletion is an important indicator for tyrosine kinase inhibitor treatment in non-small cell lung cancer. However, detection of exon 19 deletions faces a challenge: there are more than 30 types of mutations reported at the hotspot. Moreover, considering the application in body fluid samples, assays with high sensitivity and specificity are necessary for the detection of rare mutant alleles. Here, we describe a single tube reaction which could detect at least 29 types of exon 19 deletions with only an unlabeled peptide nucleic acid (PNA) clamp and a pair of DNA probes. The PNA clamp was used to inhibit amplification of wild-type templates; and the DNA probes were used to generate melting peaks for multiple types of mutations. Under optimal condition, the assay was able to detect as low as 0.01% mutant DNA in wild-type background, and had a limit of detection of 10 pg genomic DNA. Feasibility of the assay was tested in body fluid samples from lung cancer patients. The assay detected 100% and 60% of deletions in pleural effusions and plasma, respectively. We believe the present assay can be used in the clinical laboratories and has potential to be adapted for a microfluidic device.

摘要

表皮生长因子受体(EGFR)第19外显子缺失是非小细胞肺癌中酪氨酸激酶抑制剂治疗的重要指标。然而,检测第19外显子缺失面临一项挑战:在该热点区域已报道有30多种类型的突变。此外,考虑到在体液样本中的应用,对于罕见突变等位基因的检测,需要高灵敏度和特异性的检测方法。在此,我们描述了一种单管反应,该反应仅使用一个未标记的肽核酸(PNA)夹和一对DNA探针就能检测至少29种类型的第19外显子缺失。PNA夹用于抑制野生型模板的扩增;DNA探针用于产生多种类型突变的熔解峰。在最佳条件下,该检测方法能够在野生型背景中检测低至0.01%的突变DNA,检测限为10 pg基因组DNA。在肺癌患者的体液样本中测试了该检测方法的可行性。该检测方法分别在胸腔积液和血浆中检测到100%和60%的缺失。我们相信目前的检测方法可用于临床实验室,并有可能适用于微流控设备。

相似文献

1
A primer and probe set for detecting multiple types of EGFR exon 19 deletions.一种用于检测多种类型表皮生长因子受体(EGFR)第19外显子缺失的引物和探针组。
Anal Biochem. 2016 Nov 15;513:61-67. doi: 10.1016/j.ab.2016.09.002. Epub 2016 Sep 4.
2
Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.利用胸腔积液样本和肽核酸探针检测法预测非小细胞肺癌患者表皮生长因子受体靶向治疗的疗效
Clin Chem Lab Med. 2017 Oct 26;55(12):1979-1986. doi: 10.1515/cclm-2016-0809.
3
Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.采用 PNA 钳夹和直接测序法检测并比较伴有恶性胸腔积液的 NSCLC 患者的配对肿瘤组织、细胞块、胸腔积液和血清中的 EGFR 突变。
Lung Cancer. 2013 Aug;81(2):207-12. doi: 10.1016/j.lungcan.2013.04.023. Epub 2013 May 29.
4
Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.鉴定恶性胸腔积液和脑脊液中具有激活 EGFR 突变的非小细胞肺癌:免疫细胞化学快速敏感检测外显子 19 缺失 E746-A750 和外显子 21 L858R 突变。
Lung Cancer. 2011 Oct;74(1):35-40. doi: 10.1016/j.lungcan.2011.02.002. Epub 2011 Mar 27.
5
Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.采用两种差异敏感性方法检测不同肿瘤细胞比例肺腺癌标本中的 EGFR 突变状态。
J Thorac Oncol. 2012 Feb;7(2):355-64. doi: 10.1097/JTO.0b013e31823c4c1b.
6
Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.采用双重肽核酸夹介导的锁核酸-肽核酸 PCR 夹技术,对非小细胞肺癌患者血浆样本中的表皮生长因子受体突变进行超灵敏和定量检测。
Analyst. 2019 Feb 25;144(5):1718-1724. doi: 10.1039/c8an02446d.
7
The use of EGFR exon 19 and 21 unlabeled DNA probes to screen for activating mutations in non-small cell lung cancer.使用表皮生长因子受体(EGFR)第19和21外显子未标记的DNA探针筛查非小细胞肺癌中的激活突变。
J Biomol Tech. 2008 Jul;19(3):217-24.
8
Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer.采用 PNA-LNA PCR 夹心法可靠检测非小细胞肺癌 EGFR 基因密码子 L858 处稀有突变。
Adv Exp Med Biol. 2013;756:321-31. doi: 10.1007/978-94-007-4549-0_39.
9
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.对于检测肺癌患者的表皮生长因子受体(EGFR)改变,血浆比血清是更好的肿瘤来源循环游离DNA检测样本。
Lung Cancer. 2013 Nov;82(2):373-4. doi: 10.1016/j.lungcan.2013.08.014. Epub 2013 Aug 19.
10
Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.肽核酸钳夹法与直接测序法在非小细胞肺癌患者表皮生长因子受体基因突变检测中的比较
Cancer Res Treat. 2015 Oct;47(4):661-9. doi: 10.4143/crt.2014.282. Epub 2015 Feb 23.